IOVA
Iovance Biotherapeutics, Inc.
$6.27
Earnings Summary
Revenue | $0.47Mn |
Net Profits | $-113.76Mn |
Net Profit Margins | -24255.86% |
Highlights
Iovance Biotherapeutics, Inc.’s revenue jumped +Inf% since last year same period to $0.47Mn in the Q3 2023. On a quarterly growth basis, Iovance Biotherapeutics, Inc. has generated 97.06% jump in its revenue since last 3-months.
Iovance Biotherapeutics, Inc.’s net profit fell -15.09% since last year same period to $-113.76Mn in the Q3 2023. On a quarterly growth basis, Iovance Biotherapeutics, Inc. has generated -6.79% fall in its net profits since last 3-months.
Iovance Biotherapeutics, Inc.’s net profit margin jumped NaN% since last year same period to -24255.86% in the Q3 2023. On a quarterly growth basis, Iovance Biotherapeutics, Inc. has generated 45.81% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Iovance Biotherapeutics, Inc. post its latest quarter earnings
EPS Estimate Current Quarter | -0.44 |
EPS Estimate Current Year | -0.44 |
Highlights
Iovance Biotherapeutics, Inc.’s earning per share (EPS) estimates for the current quarter stand at -0.44 - a 2.22% jump from last quarter’s estimates.
Iovance Biotherapeutics, Inc.’s earning per share (EPS) estimates for the current year stand at -0.44.
Key Ratios
Key ratios of the Iovance Biotherapeutics, Inc. post its Q3 2023 earnings
Earning Per Share (EPS) | -0.46 |
Highlights
Iovance Biotherapeutics, Inc.’s earning per share (EPS) jumped 26.98% since last year same period to -0.46 in the Q3 2023. This indicates that the Iovance Biotherapeutics, Inc. has generated 26.98% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-11-07 | -0.45 | -0.46 | -2.22% |
2023-08-08 | -0.8 | -0.47 | 41.25% |
2023-05-10 | -0.74 | -0.5 | 32.43% |
₹0 US Stocks a/c Opening Fee